Skip to content
Screener

Natera, Inc. NTRA Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$752.8MBeat by $91.5M
EPS-$0.47Beat by $0.02
Revenue estimate$661.2M
EPS estimate-$0.49
“We had an exceptional quarter helping patients, with over one million tests processed for the second consecutive quarter and record growth in oncology volumes. We also reached several landmark milestones in the last few months: Signatera™ achieved three significant regulatory approvals, Medicare coverage expanded for Prospera™, and we launched a major enhancement to our Panorama™ NIPT.”
Steve Chapman

Next report

Nov 5, 2026 (In 3 weeks)
Revenue estimate$707.4M
EPS estimate-$0.26

Financials

Q2 2026

Income statement

See full
Revenue$752.8M+37.7%
Operating income-$75.8M+31.3%
Net income-$67.0M+33.7%
EPS (diluted)-$0.47+36.5%

Balance sheet

See full
Cash & equivalents$1.1B+9.1%
Total debt$238.5M+21.6%
Total equity$1.8B+46.2%
Total assets$2.7B+51.2%

Cash flow

See full
Operating cash flow$54.8M+45.8%
CapEx$63.4M+145%

Valuation & ratios

Valuation

as of 10/09/26
See full
Market cap$56.33B+137%
Enterprise value$55.48B+142%
P/S20.8×+9.6×

Profitability

See full
Operating margin-10.7%-2.4pp

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio3×-0.7×

Segments

By geography

See full
Europe, Middle East, India, Africa$9.0M+66.7%
Americas, excluding U.S.$2.2M—
Asia Pacific and Other$2.0M—

By segment

See full
Reportable Segment$752.8M—

FAQ

When did Natera, Inc. report Q2 2026 earnings?
Natera, Inc. (NTRA) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Natera, Inc.'s Q2 2026 revenue and EPS?
Natera, Inc. reported revenue of $752.8M and eps of $-0.47 for Q2 2026.
Did Natera, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $661.2M by $91.5M. EPS beat the consensus estimate of $-0.49 by $0.02.
How did Natera, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 37.7% from $546.6M a year earlier and eps grew 36.5% from $-0.74.
Where can I find Natera, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001604821-26-000015) and the 10-Q periodic report (0001628280-26-054525) directly on SEC EDGAR. The filing index links above go to sec.gov.